Suppr超能文献

转录因子疗法:有望成功还是无足轻重?

Transcription factor therapeutics: long-shot or lodestone.

作者信息

Ghosh David, Papavassiliou Athanasios G

机构信息

Institute for Transcriptional Informatics, PO Box 2556, Pittsburgh, PA 15230, USA.

出版信息

Curr Med Chem. 2005;12(6):691-701. doi: 10.2174/0929867053202197.

Abstract

Many drugs, both approved and in development, exert their effects through transcription factors. The complexity of the biology of transcriptional regulation, however, presents challenges to the effective design of therapies that directly target transcription factors. This review focuses on the different approaches that are currently pursued in therapeutics and drug discovery aimed at targeting transcription factors and signaling molecules, and their areas of effect in transcription factor biology. A relatively recent approach termed "transcription therapy" has been applied for a number of drugs in development, which may potentially provide a new avenue for targeting transcription factors for therapeutic purposes.

摘要

许多已获批准以及正在研发的药物都是通过转录因子发挥作用的。然而,转录调控生物学的复杂性给直接靶向转录因子的有效疗法设计带来了挑战。本综述聚焦于目前在治疗学和药物研发中针对转录因子和信号分子所采用的不同方法,以及它们在转录因子生物学中的作用领域。一种相对较新的方法,即“转录疗法”,已应用于多种正在研发的药物,这可能为以治疗为目的靶向转录因子提供一条新途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验